NMPA Approval

Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Approval Number

国药准字H20233037

Company宁波美舒医药科技有限公司

Registration Date

January 10, 2023

Drug Information

Generic Name

奥美沙坦酯氢氯噻嗪片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg与氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

January 10, 2023

Company Information

Applicant Company

Company Name宁波美舒医药科技有限公司

Company Address

浙江省宁波高新区扬帆路999弄1号＜13-3＞＜14-3＞

Manufacturing Company

Company Name宁波美诺华天康药业有限公司

Company Address

浙江省宁波市北仑区大榭街道滨海西路85号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氢氯噻嗪片 - NMPA 批准文号 | MedPath